“…The CMV gB gene has been mapped in the genomes of strain AD169 (Cranage et al, 1986;Mach et al, 1986) and Towne Spaete et al, 1988). This glycoprotein is produced as a full-length precursor, which is glycosylated (Britt & Auger, 1986;Pereira et al, 1984;Rasmussen et aL, 1985bRasmussen et aL, , 1988 and proteolytically cleaved between residues 460 and 461 after its synthesis (Spaete et al, 1988(Spaete et al, , 1990. It is highly immunogenic in natural infection and elicits a strong humoral immune response in humans (Cremer et al, 1985;Kniess et al, 1991;Pereira et al, 1982Pereira et al, , 1983Rasmussen et al, 1991) and in animals experimentally immunized with the glycoprotein (Britt et al, 1988;Gonczol et al 1986;Rasmussen et al, 1985a).…”